| MIPS 001 | Diabetes: Glycemic Status Assessment Greater Than 9% | High Priority | Benchmark |
| MIPS 005 | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or | Process | Topped Out |
| MIPS 006 | Coronary Artery Disease (CAD): Antiplatelet Therapy | Process | Topped Out |
| MIPS 007 | Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial | Process | Topped Out |
| MIPS 008 | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic | Process | Topped Out |
| MIPS 024 | Communication with the Physician or Other Clinician Managing On-Going Care Post- | High Priority | Topped Out |
| MIPS 039 | Screening for Osteoporosis for Women Aged 65-85 Years of Age | Process | Benchmark |
| MIPS 047 | Advance Care Plan | High Priority | Topped Out |
| MIPS 048 | Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in | Process | Topped Out |
| MIPS 050 | Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years | High Priority | Topped Out |
| MIPS 052 | Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation and Long-Acting | Process | Topped Out |
| MIPS 065 | Appropriate Treatment for Upper Respiratory Infection (URI) | High Priority | Topped Out |
| MIPS 066 | Appropriate Testing for Pharyngitis | High Priority | Topped Out |
| MIPS 102 | Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate | High Priority | Benchmark |
| MIPS 112 | Breast Cancer Screening | Process | — |
| MIPS 113 | Colorectal Cancer Screening | Process | — |
| MIPS 116 | Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis | High Priority | Topped Out |
| MIPS 117 | Diabetes: Eye Exam | Process | Topped Out |
| MIPS 118 | Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) | Process | Topped Out |
| MIPS 126 | Diabetes Mellitus: Diabetic Foot and Ankle Care Peripheral Neuropathy – Neurological Evaluation | Process | Topped Out |
| MIPS 127 | Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of | Process | Topped Out |
| MIPS 128 | Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan | Process | — |
| MIPS 130 | Documentation of Current Medications in the Medical Record | High Priority | Topped Out |
| MIPS 134 | Preventive Care and Screening: Screening for Depression and Follow-Up Plan | Process | Topped Out |
| MIPS 141 | Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 20% OR | High Priority | Topped Out |
| MIPS 143 | Oncology: Medical and Radiation – Pain Intensity Quantified | High Priority | Topped Out |
| MIPS 144 | Oncology: Medical and Radiation – Plan of Care for Pain | High Priority | Topped Out |
| MIPS 145 | Radiology: Exposure Dose Indices Reported for Procedures Using Fluoroscopy | High Priority | Topped Out |
| MIPS 155 | Falls: Plan of Care | High Priority | Topped Out |
| MIPS 164 | Coronary Artery Bypass Graft (CABG): Prolonged Intubation | High Priority | Benchmark |
| MIPS 167 | Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure | High Priority | Benchmark |
| MIPS 168 | Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration | High Priority | Benchmark |
| MIPS 176 | Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response | Process | Topped Out |
| MIPS 177 | Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity | Process | Topped Out |
| MIPS 178 | Rheumatoid Arthritis (RA): Functional Status Assessment | Process | Topped Out |
| MIPS 180 | Rheumatoid Arthritis (RA): Glucocorticoid Management | Process | Topped Out |
| MIPS 181 | Elder Maltreatment Screen and Follow-Up Plan | High Priority | Topped Out |
| MIPS 182 | Functional Outcome Assessment | High Priority | Topped Out |
| MIPS 187 | Stroke and Stroke Rehabilitation: Thrombolytic Therapy | Process | Topped Out |
| MIPS 191 | Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery | High Priority | Topped Out |
| MIPS 205 | Sexually Transmitted Infection (STI) Testing for People with HIV | Process | Benchmark |
| MIPS 217 | Functional Status Change for Patients with Knee Impairments | High Priority | Benchmark |
| MIPS 218 | Functional Status Change for Patients with Hip Impairments | High Priority | Benchmark |
| MIPS 219 | Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairments | High Priority | Benchmark |
| MIPS 220 | Functional Status Change for Patients with Low Back Impairments | High Priority | Benchmark |
| MIPS 221 | Functional Status Change for Patients with Shoulder Impairments | High Priority | Benchmark |
| MIPS 222 | Functional Status Change for Patients with Elbow, Wrist or Hand Impairments | High Priority | Benchmark |
| MIPS 226 | Preventive Care and Screening: Tobacco Use: Screening and Cessation | Process | Topped Out |
| MIPS 236 | Controlling High Blood Pressure | High Priority | Benchmark |
| MIPS 238 | Use of High-Risk Medications in Older Adults | High Priority | Topped Out |
| MIPS 243 | Cardiac Rehabilitation Patient Referral from an Outpatient Setting | High Priority | Benchmark |
| MIPS 249 | Barrett’s Esophagus | Process | Topped Out |
| MIPS 250 | Radical Prostatectomy Pathology Reporting | Process | Topped Out |
| MIPS 259 | Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured | High Priority | Benchmark |
| MIPS 261 | Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness | High Priority | Benchmark |
| MIPS 268 | Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy | Process | Topped Out |
| MIPS 275 | Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before | Process | Benchmark |
| MIPS 277 | Sleep Apnea: Severity Assessment at Initial Diagnosis | Process | Topped Out |
| MIPS 279 | Sleep Apnea: Assessment of Adherence to Obstructive Sleep Apnea (OSA) Therapy | Process | Topped Out |
| MIPS 282 | Dementia: Functional Status Assessment | Process | Topped Out |
| MIPS 286 | Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia | High Priority | Topped Out |
| MIPS 288 | Dementia: Education and Support of Caregivers for Patients with Dementia | High Priority | Topped Out |
| MIPS 291 | Assessment of Cognitive Impairment or Dysfunction for Patients with Parkinson’s | Process | Topped Out |
| MIPS 293 | Rehabilitative Therapy Referral for Patients with Parkinson’s Disease | High Priority | Topped Out |
| MIPS 303 | Cataracts: Improvement in Patient’s Visual Function within 90 Days Following Cataract | High Priority | Benchmark |
| MIPS 304 | Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery | High Priority | Benchmark |
| MIPS 317 | Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up | Process | Topped Out |
| MIPS 320 | Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients | High Priority | Topped Out |
| MIPS 326 | Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy | Process | Topped Out |
| MIPS 331 | Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse) | High Priority | Benchmark |
| MIPS 332 | Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate | High Priority | Topped Out |
| MIPS 335 | Maternity Care: Elective Delivery (Without Medical Indication) at < 39 Weeks (Overuse) | High Priority | Benchmark |
| MIPS 336 | Maternity Care: Postpartum Follow-up and Care Coordination | High Priority | Benchmark |
| MIPS 338 | HIV Viral Suppression | High Priority | Topped Out |
| MIPS 340 | HIV Annual Retention in Care | High Priority | Benchmark |
| MIPS 344 | Rate of Carotid Endarterectomy (CEA) or Carotid Artery Stenting (CAS) for | High Priority | Benchmark |
| MIPS 350 | Total Knee or Hip Replacement: Shared Decision-Making: Trial of Conservative (Non- | High Priority | Topped Out |
| MIPS 351 | Total Knee or Hip Replacement: Venous Thromboembolic and Cardiovascular Risk | High Priority | Topped Out |
| MIPS 354 | Anastomotic Leak Intervention | High Priority | Benchmark |
| MIPS 355 | Unplanned Reoperation within the 30-Day Postoperative Period | High Priority | Benchmark |
| MIPS 356 | Unplanned Hospital Readmission within 30 Days of Principal Procedure | High Priority | Benchmark |
| MIPS 357 | Surgical Site Infection (SSI) | High Priority | Benchmark |
| MIPS 358 | Patient-Centered Surgical Risk Assessment and Communication | High Priority | Topped Out |
| MIPS 360 | Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose | High Priority | Topped Out |
| MIPS 364 | Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT | High Priority | Topped Out |
| MIPS 370 | Depression Remission at Twelve Months | High Priority | Benchmark |
| MIPS 374 | Closing the Referral Loop: Receipt of Specialist Report | High Priority | Topped Out |
| MIPS 383 | Adherence to Antipsychotic Medications For Individuals with Schizophrenia | High Priority | Benchmark |
| MIPS 384 | Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating | High Priority | Topped Out |
| MIPS 385 | Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement | High Priority | Benchmark |
| MIPS 386 | Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences | High Priority | Benchmark |
| MIPS 387 | Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users | Process | Benchmark |
| MIPS 389 | Cataract Surgery: Difference Between Planned and Final Refraction | High Priority | Benchmark |
| MIPS 392 | Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation | High Priority | Benchmark |
| MIPS 393 | Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, | High Priority | Benchmark |
| MIPS 394 | Immunizations for Adolescents | Process | Benchmark |
| MIPS 395 | Lung Cancer Reporting (Biopsy/Cytology Specimens) | High Priority | Topped Out |
| MIPS 396 | Lung Cancer Reporting (Resection Specimens) | High Priority | Topped Out |
| MIPS 397 | Melanoma Reporting | High Priority | Topped Out |
| MIPS 398 | Optimal Asthma Control | High Priority | Benchmark |
| MIPS 400 | One-Time Screening for Hepatitis C Virus (HCV) and Treatment Initiation | Process | Benchmark |
| MIPS 401 | Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis | Process | Benchmark |
| MIPS 404 | Anesthesiology Smoking Abstinence | High Priority | Benchmark |
| MIPS 405 | Appropriate Follow-up Imaging for Incidental Abdominal Lesions | High Priority | Topped Out |
| MIPS 406 | Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients | High Priority | Topped Out |
| MIPS 410 | Psoriasis: Clinical Response to Systemic Medications | High Priority | Benchmark |
| MIPS 413 | Door to Puncture Time for Endovascular Stroke Treatment | High Priority | Benchmark |
| MIPS 415 | Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt | High Priority | Topped Out |
| MIPS 416 | Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt | High Priority | Benchmark |
| MIPS 418 | Osteoporosis Management in Women Who Had a Fracture | Process | Benchmark |
| MIPS 420 | Varicose Vein Treatment with Saphenous Ablation: Outcome Survey | High Priority | Benchmark |
| MIPS 421 | Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal | Process | Benchmark |
| MIPS 422 | Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse | High Priority | Benchmark |
| MIPS 430 | Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy | High Priority | Topped Out |
| MIPS 431 | Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief | Process | Benchmark |
| MIPS 432 | Proportion of Patients Sustaining a Bladder or Bowel Injury at the time of any Pelvic | High Priority | Benchmark |
| MIPS 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | Process | Benchmark |
| MIPS 440 | Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician | High Priority | Topped Out |
| MIPS 441 | Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control) | High Priority | Benchmark |
| MIPS 445 | Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG) | High Priority | Benchmark |
| MIPS 448 | Appropriate Workup Prior to Endometrial Ablation | High Priority | Benchmark |
| MIPS 450 | Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive | High Priority | Topped Out |
| MIPS 451 | RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with | Process | Benchmark |
| MIPS 453 | Percentage of Patients who Died from Cancer Receiving Systemic Cancer-Directed | High Priority | Benchmark |
| MIPS 457 | Percentage of Patients who Died from Cancer Admitted to Hospice for Less than 3 | High Priority | Topped Out |
| MIPS 459 | Back Pain After Lumbar Surgery | High Priority | Benchmark |
| MIPS 461 | Leg Pain After Lumbar Surgery | High Priority | Benchmark |
| MIPS 463 | Prevention of Post-Operative Vomiting (POV) – Combination Therapy (Pediatrics) | High Priority | Topped Out |
| MIPS 464 | Otitis Media with Effusion: Systemic Antimicrobials - Avoidance of | High Priority | Topped Out |
| MIPS 465 | Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints | High Priority | Benchmark |
| MIPS 468 | Continuity of Pharmacotherapy for Opioid Use Disorder (OUD) | High Priority | Benchmark |
| MIPS 470 | Functional Status After Primary Total Knee Replacement | High Priority | Benchmark |
| MIPS 471 | Functional Status After Lumbar Surgery | High Priority | Benchmark |
| MIPS 477 | Multimodal Pain Management | High Priority | Topped Out |
| MIPS 478 | Functional Status Change for Patients with Neck Impairments | High Priority | Benchmark |
| MIPS 482 | Hemodialysis Vascular Access: Practitioner Level Long-term Catheter Rate | High Priority | Benchmark |
| MIPS 483 | Person-Centered Primary Care Measure Patient Reported Outcome | High Priority | Benchmark |
| MIPS 485 | Psoriasis – Improvement in Patient-Reported Itch Severity | High Priority | Benchmark |
| MIPS 486 | Dermatitis – Improvement in Patient-Reported Itch Severity | High Priority | Benchmark |
| MIPS 488 | Kidney Health Evaluation | Process | Benchmark |
| MIPS 489 | Adult Kidney Disease: Angiotensin Converting Enzyme (ACE) Inhibitor or | Process | Topped Out |
| MIPS 490 | Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated | Process | Benchmark |
| MIPS 491 | Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing | High Priority | Topped Out |
| MIPS 493 | Adult Immunization Status | Process | Benchmark |
| MIPS 495 | Ambulatory Palliative Care Patients’ Experience of Feeling Heard and | High Priority | Benchmark |
| MIPS 496 | Cardiovascular Disease (CVD) Risk Assessment Measure - Proportion of | Process | Benchmark |
| MIPS 497 | Preventive Care and Wellness (Composite) | Process | Benchmark |
| MIPS 499 | Appropriate Screening and Plan of Care for Elevated Intraocular Pressure Following | Process | Benchmark |
| MIPS 500 | Acute Posterior Vitreous Detachment Appropriate Examination and Follow-up | Process | Benchmark |
| MIPS 501 | Acute Posterior Vitreous Detachment and Acute Vitreous Hemorrhage Appropriate | Process | Benchmark |
| MIPS 502 | Improvement or Maintenance of Functioning for Individuals with a Mental and/or | High Priority | Benchmark |
| MIPS 503 | Gains in Patient Activation Measure (PAM) Scores at 12 Months | High Priority | Benchmark |
| MIPS 504 | Initiation, Review, and/or Update to Suicide Safety Plan for Individuals with Suicidal | High Priority | Benchmark |
| MIPS 505 | Reduction in Suicidal Ideation or Behavior Symptoms | High Priority | Benchmark |
| MIPS 506 | Positive PD-L1 Biomarker Expression Test Result Prior to First-Line Immune Checkpoint | High Priority | Benchmark |
| MIPS 507 | Appropriate Germline Testing for Ovarian Cancer Patients | Process | Benchmark |
| MIPS 509 | Melanoma: Tracking and Evaluation of Recurrence | High Priority | Benchmark |
| MIPS 510 | First Year Standardized Kidney Transplant Waitlist Ratio (FYSWR) | Process | Benchmark |
| MIPS 511 | Percentage of Prevalent Patients Waitlisted for Kidney Transplant (PPPW) and | Process | Benchmark |
| MIPS 512 | Prevalent Standardized Kidney Transplant Waitlist Ratio (PSWR) | Process | Benchmark |
| MIPS 513 | Patient Reported Falls and Plan of Care | Process | Benchmark |
| MIPS 516 | Hepatitis C Virus (HCV): Sustained Virological Response (SVR) | High Priority | Benchmark |